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Introduction
Endometrial cancer remains one of the most common gynecological malignancies reported worldwide, with a rather favorable prognostic especially in cases diagnosed in early stages of disease (1, 2) .
However, in certain cases, especially when diagnosed in advanced stages, this malignancy might recur via various pathways of dissemination including lymphatic or hematogenous route (3) . In this way, the most common sites of relapse include bones, liver, lungs and lymphatic system. In rare cases distant metastases might develop in atypical locations such as heart, eye, breast, kidney or skin. When it comes to the skin and subcutaneous metastases, this represents a rare eventuality, being most often reported in lung cancer (in male) and in breast cancer respectively (in female) (4, 5) . In the meantime, cutaneous and subcutaneous metastases from endometrial cancer represent a very rare condition, only few cases being reported so far (5-
7).
Case Report 
Discussion
Whenever a patient with previous history of endometrial adenocarcinoma presents for the apparition of cutaneous lesions, the first answer which should be answered is if these lesions are metastases or paraneoplastic lesions. Paraneoplastic lesions are usually induced by various substances released by the Subcutaneous metastasis from endometrial cancer 39 tumor (such as growth factors, cytokines or hormones) while skin metastases are produced by the tumoral dissemination via hematogenous, lymphatic route or even via contiguity. In order to distinguish between these two pathological entities, biopsy and histopathological examination are mandatory (6, 8, 9) .
Skin metastases from endometrial cancer are a rare eventuality, with an estimated incidence of 0.8% (10) which usually occurs as part of systemic disease.
Therefore For example, a recent report coming from the surgeons from Virginia, United States of America (17) presented a case of a 62-year-old postmenopausal woman who initially presented for the apparition of an erythematous rash and nodules on the lower abdomen, vulva and neck; the biopsy of one of these lesions demonstrated a papillary serous carcinoma while the computed tomography showed the presence of a thickened endometrial lining which was also biopsied, the same histopathological aspect being revealed.
Although the patient was submitted immediately to carboplatin and paclitaxel chemotherapy in association with palliative radiotherapy she died at 10 months after initial presentation (17) .
In the meantime, the surgeons from Konya, Turkey, 
40
months follow-up the patient was diagnosed with a solitary lesion measuring 6/3 cm in the proximity of the previous laparotomy line so she was resubmitted to surgery, the lesion being removed with negative resection margins. The histopathological studies confirmed the metastatic origin of the lesion; therefore, the patient was submitted to adjuvant radio chemotherapy (19) . In our case the diagnostic of the subcutaneous lesion as oligometastatic disease transformed the patient in a perfect candidate for surgery with curative intent.
Conclusions
Subcutaneous and cutaneous metastases from endometrial cancer are rare eventualities which are usually diagnosed as part of systemic dissemination of this malignancy; in these cases, the patient is only candidate for oncological treatment with palliative intent. In certain cases in which the lesions occur as oligometastatic disease, surgery might be performed with curative intent.
